Form 4: Regal Rexnord CFO Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Regal Rexnord's EVP and CFO, Robert Rehard, reported the sale of 2,257 shares of common stock in late February 2026.

Summary

  • Robert Rehard, Executive Vice President and Chief Financial Officer of Regal Rexnord Corp (RRX), reported the sale of common stock.
  • A total of 1,289 shares were sold on February 24, 2026, at a weighted average price of $223.13 per share, with prices ranging from $223.00 to $223.24.
  • An additional 968 shares were sold on February 25, 2026, at a price of $223.00 per share.
  • These transactions were conducted pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale.
  • Following these transactions, Robert Rehard beneficially owns 34,446.954 shares of common stock.
  • The filing also details various Stock Appreciation Rights (SARs) held by Mr. Rehard, with exercise prices ranging from $74.04 to $168.47 and expiration dates between 2027 and 2034.
  • SARs vest according to two schedules: 40/60/80/100% over five years or 34/67/100% over three years from the grant date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The insider sale, while a reduction in executive holdings, was pre-scheduled under a 10b5-1 plan, which mitigates concerns about its implications for the company's future prospects.

Positives

  • The reported stock sales were executed under a Rule 10b5-1(c) plan, which demonstrates a pre-scheduled transaction for personal financial planning rather than an opportunistic sale based on non-public information.

Negatives

  • Insider selling, even under a 10b5-1 plan, can sometimes be perceived by the market as a lack of strong conviction in the company's near-term stock performance, although this is often for personal liquidity or diversification.

Risks

  • No specific risks related to the company's operations or financial health are disclosed in this Form 4 filing, as it primarily reports insider transactions.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

  • The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Industry Context

StockSavvy.ai notes that insider sales, particularly those executed under Rule 10b5-1 plans, are a common occurrence for executives managing personal financial portfolios, diversifying holdings, or meeting liquidity needs. Such pre-arranged sales typically carry less signaling weight than unscheduled, open-market transactions.

Related Party Transactions

  • Sale of 2,257 shares of common stock by Robert Rehard, EVP and CFO, to manage personal financial holdings.

Stakeholder Impact

  • Shareholders: The sale represents a minor dilution of outstanding shares, but the impact is negligible given the small volume relative to the company's total market capitalization.
  • Employees: No direct impact on employees is indicated by this filing.
  • Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.

Key Dates

DateDescription
05/10/2019Grant date for Stock Appreciation Rights with an exercise price of $76.99, expiring 05/10/2027.
05/09/2020Grant date for Stock Appreciation Rights with an exercise price of $74.04, expiring 05/09/2028.
02/18/2021Grant date for Stock Appreciation Rights with an exercise price of $84.39, expiring 02/18/2030.
05/08/2021Grant date for Stock Appreciation Rights with an exercise price of $78.05, expiring 05/08/2029.
02/23/2022Grant date for Stock Appreciation Rights with an exercise price of $133.77, expiring 02/23/2031.
02/23/2023Grant date for Stock Appreciation Rights with an exercise price of $151.27, expiring 02/23/2032.
02/23/2024Grant date for Stock Appreciation Rights with an exercise price of $154.20, expiring 02/23/2033.
02/23/2025Grant date for Stock Appreciation Rights with an exercise price of $168.47, expiring 02/23/2034.
02/24/2026Transaction date for the sale of 1,289 shares of Common Stock by Robert Rehard.
02/25/2026Transaction date for the sale of 968 shares of Common Stock by Robert Rehard.
02/26/2026Signature date of the Form 4 filing.

Recommendation

hold

A 'hold' recommendation is appropriate as this Form 4 filing primarily reports a routine insider transaction under a 10b5-1 plan. Such transactions are generally for personal financial management and do not typically provide strong signals for a 'buy' or 'sell' decision on their own. Investors should consider broader company fundamentals and market conditions.

Keywords

Regal Rexnord, RRX, Insider Trading, Form 4, Stock Sale, Executive Compensation, Robert Rehard, CFO, 10b5-1 Plan, Stock Appreciation Rights

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.